Results 241 to 250 of about 647,551 (301)

A Novel Microfluidic System for 3D Epidermis and Full‐Thickness Skin Growth for Nanoparticle Safety Assessment

Advanced Healthcare Materials, EarlyView.
This work presents a novel, dynamically perfused, configurable microfluidic system for epidermis‐only (E and full‐thickness skin (FT SoC) growth, emulating human skin structure and barrier function. Upon TiO2 nanoparticle exposure, the system reveals compromised barrier integrity, reduced metabolic activity, increased permeability, and chemokine‐driven
Samantha Costa, Ana B. Carneiro, Filipa Lebre, João Meneses, Alar Ainla, Cacilda Moura, Ernesto Alfaro‐Moreno, Ana R. Ribeiro   +7 more
wiley   +1 more source

A Machine Learning Algorithm to Predict Medical Device Recall by the Food and Drug Administration. [PDF]

West J Emerg Med
Barbosa Slivinskis V, Agi Maluli I, Seth Broder J.   +2 more
europepmc   +1 more source

Bioengineered Pancreatic Cancer Immunosuppressive Microenvironment Models for Screening Immunotherapies

Advanced Healthcare Materials, EarlyView.
Bioengineering tumor‐stroma pancreatic cancer models with potential to emulate the native immunosuppressive tumor microenvironment. Cancer‐on‐a‐bead models exhibited higher relevance for screening immunotherapies and modulating the protumoral PDAC microenvironment. ABSTRACT Pancreatic cancer is notably resistant to treatment, primarily due to its dense
Maria V. Monteiro, Margarida Henriques‐Pereira, Bruno M. Neves, Vítor M. Gaspar, João F. Mano   +4 more
wiley   +1 more source

Response to "The Role of Patient- and Drug-Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System". [PDF]

J Cosmet Dermatol
Zaminski D, Garshick M, Shapiro J, Sicco KL, Mazori DR.   +4 more
europepmc   +1 more source

Transforming medical education: Embracing innovative animal simulation in compliance with Food and Drug Administration Modernization Act 2.0 guidelines

Shirish Joshi, Jay Maradia, Rajmohan Seetharaman, Amitoj Sohal   +3 more
openalex   +1 more source

Growth Hormone‐Loaded 3D Printed Silk Fibroin‐Cellulose Dressings for Ischemic Wounds

Advanced Healthcare Materials, EarlyView.
3D‐printed wound dressings combining carboxymethyl cellulose, silk fibroin, and growth hormone accelerate healing in diabetic ulcers. These bioactive, customizable dressings enhance angiogenesis, cellular proliferation, and immune modulation. Proteomic analysis reveals activation of regenerative pathways and reduced fibrosis, highlighting their ...
Maria Pita‐Vilar, Diego Caicedo‐Valdés, Susana B. Bravo, Isabel Rodriguez‐Moldes, Salvador D. Aznar‐Cervantes, Angel Concheiro, Carmen Alvarez‐Lorenzo, Luis Diaz‐Gomez   +7 more
wiley   +1 more source

Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009-2023). [PDF]

Eur J Cancer
Iannantuono GM, Floudas CS, Filetti M, Giovagnoli T, Sganga S, Vitale A, Chandran E, Lombardi P, Rosenfeld R, Giudice E, Xue E, Rapisarda E, Troisi P, Apolo AB, Karzai F, Bria E, Gulley JL, Daniele G.   +17 more
europepmc   +1 more source

Corrigendum to A Review of the Food and Drug Administration Pipeline and Proposed California Legislation on Medicinal Psychedelics. [PDF]

Perm J
europepmc   +1 more source

Thromboembolic events associated with angiogenesis inhibitors: a real-world study of data from the food and drug administration adverse event reporting system (FAERS) database. [PDF]

Thromb J
Zhou J, Wu M, Chen T, Niu P, Zhu Y, Liu Y, Chen H, Zeng X, Zhang J.   +8 more
europepmc   +1 more source

Interpretive agreement of susceptibility between broth microdilution and disk diffusion methods for cefiderocol, using criteria from the Clinical and Laboratory Standards Institute, European Committee on Antimicrobial Susceptibility Testing, and the Food and Drug Administration. [PDF]

J Clin Microbiol
Lin Y-T, Lin H-H, Chen C-H, Tseng K-H, Ho M-W, Hsueh P-R.   +5 more
europepmc   +1 more source